BioMarin Pharmaceutical, Inc. (BMRN)

63.59 +0.17 (+0.27%) USD  |  NASDAQ  |  Feb 20, 10:26
More

BioMarin Pharmaceutical Price Target Std Dev

Price Target Std Dev Chart

View Price Target Std Dev for BMRN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Price Target Std Dev Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Price Target Std Dev Range, Past 5 Years

View Price Target Std Dev Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price Target Std Dev Benchmarks

View Price Target Std Dev Benchmarks
Start Trial
Amicus Therapeutics, Inc. Upgrade
Gilead Sciences, Inc. Upgrade
Merck & Co., Inc. Upgrade
AbbVie, Inc. Upgrade
Biogen, Inc. Upgrade